Novavax executives told investors that there is uncertainty surrounding the company s ability to fund operations as the COVID-19 vaccine market changes
MONTREAL - The Quebec government says it's looking to find a buyer for Medicago Inc., the Quebec-based COVID-19 vaccine manufacturer that will be shut down by parent company Mitsubishi Chemical.
TORONTO At age 70, retired nurse Donna Lessard can expect to be towards the front of the line for a COVID-19 vaccine when supply and distribution expands in coming months. But instead, she s opted for an unproven vaccine candidate she can have now a two-dose product by the Quebec City-based biopharmaceutical Medicago currently running Phase 2 clinical trials. Because the trials are blinded, the Montrealer doesn t know if last month she received a second dose of the prospective vaccine or a placebo, and may not know for a year well after most Canadians are expected to receive one of several licensed vaccines.